ClinVar Miner

Submissions for variant NM_152564.5(VPS13B):c.467_470del (p.Asn156fs)

dbSNP: rs386834090
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000050081 SCV001586252 pathogenic Cohen syndrome 2023-07-07 criteria provided, single submitter clinical testing This premature translational stop signal has been observed in individual(s) with Cohen syndrome (PMID: 15141358). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 56668). This variant is also known as c.463_466delATAA. This variant is present in population databases (rs386834090, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Asn156Ilefs*4) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111).
Ambry Genetics RCV002336201 SCV002638135 pathogenic Inborn genetic diseases 2020-06-16 criteria provided, single submitter clinical testing The c.467_470delATAA variant, located in coding exon 4 of the VPS13B gene, results from a deletion of 4 nucleotides at nucleotide positions 467 to 470, causing a translational frameshift with a predicted alternate stop codon (p.N156Ifs*4). This alteration was detected in a homozygous state in an individual with Cohen Syndrome (Kolehmainen J et al. Am. J. Hum. Genet., 2004 Jul;75:122-7). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center RCV000050081 SCV004807480 uncertain significance Cohen syndrome 2024-03-29 criteria provided, single submitter clinical testing
Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM) RCV000050081 SCV000082490 probable-pathogenic Cohen syndrome no assertion criteria provided not provided Converted during submission to Likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.